FDX1 and lung carcinoma: Yun et al. identified FDX1-rs10488764 as a lung cancer risk polymorphism among smokers and non-smokers as well as three different pathological subgroups, which provided new clues to the role of FDX1 in disease development (Yun et al., 2022).